pirfenidone has been researched along with Adverse Drug Event in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JH; Kim, DW; Park, CW; Yang, MS | 1 |
| Brown, AW; de Andrade, JA; Flaherty, KR; Kaner, RJ; King, CS; Nathan, SD; Noth, I; Padilla, ML; Rahaghi, FF; Safdar, Z; Scholand, MB; Shifren, A | 1 |
| Miao, K; Tian, X; Xu, W; Xu, Y; Zhang, L; Zhang, Y | 1 |
| Chaudhuri, N; Hayton, C | 1 |
| Cottin, V | 1 |
| Bendstrup, E; Costabel, U; Cottin, V; Dewint, P; Egan, JJ; Ferguson, J; Groves, R; Hellström, PM; Kreuter, M; Maher, TM; Molina-Molina, M; Nordlind, K; Sarafidis, A; Vancheri, C | 1 |
3 review(s) available for pirfenidone and Adverse Drug Event
| Article | Year |
|---|---|
Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Decision Making; Disease Management; Drug-Related Side Effects and Adverse Reactions; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Pyridones; Vital Capacity | 2017 |
The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Prevalence; Pyridones; Risk Factors; Survival Rate; Treatment Outcome | 2013 |
Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Disease Management; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Humans; Idiopathic Pulmonary Fibrosis; Pyridones; Respiratory Function Tests; Tumor Necrosis Factor-alpha | 2014 |
3 other study(ies) available for pirfenidone and Adverse Drug Event
| Article | Year |
|---|---|
Topics: Animals; Biological Availability; Bleomycin; Drug-Related Side Effects and Adverse Reactions; Excipients; Pyridones; Rats | 2022 |
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Consensus; Delphi Technique; Disease Management; Drug-Related Side Effects and Adverse Reactions; Humans; Idiopathic Pulmonary Fibrosis; Practice Patterns, Physicians'; Pyridones; Treatment Outcome | 2020 |
Treatment of steroid-resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Humans; Lung Neoplasms; Male; Pneumonia; Pyridones | 2021 |